Remigius U. agu
Professor
College of Pharmacy
Dalhousie University
Canada
Biography
Dr. REMIGIUS U. AGU is affiliated to College of Pharmacy, Dalhousie University. Dr. REMIGIUS U. AGU is currently providing services as Professor. Dr. REMIGIUS U. AGU has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. REMIGIUS U. AGU contributions have acclaimed recognition from honourable subject experts around the world. Dr. REMIGIUS U. AGU is actively associated with different societies and academies. Dr. REMIGIUS U. AGU academic career is decorated with several reputed awards and funding. Dr. REMIGIUS U. AGU research interests include Development and optimization of novel respiratory drug delivery systems and screening methods. This involves basic, applied and translational research that spans across tissue culture development, drug transporter screening, drug formulation and delivery for potential treatment of hyperthyroidism, pain and chronic inflammatory respiratory diseases..
Research Interest
Development and optimization of novel respiratory drug delivery systems and screening methods. This involves basic, applied and translational research that spans across tissue culture development, drug transporter screening, drug formulation and delivery for potential treatment of hyperthyroidism, pain and chronic inflammatory respiratory diseases.
Publications
-
Agu RU, Cowley E, Shao D, Macdonald C, Kirkpatrick D, Renton K, Massoud E. Proton-coupled oligopeptide transporter (POT) family expression in human nasal epithelium and their drug transport potential. Molecular Pharmaceutics. 2011 Jun 6;8(3):664-72.
-
Shao D, Massoud E, Clarke D, Cowley E, Renton K, Agu RU. Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro. International Journal of Pharmaceutics. 2013 Jan 30; 441(1-2):334-42.
-
Macdonald C, Shao D, Oli A, Agu RU. Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies. Journal of Drug Targeting. 2013 Jan; 21(1):97-106.
